Deployment of LifeSphere® Safety across three regions reinforces momentum for AI-powered PV transformation

Boston, Massachusetts, USA – August 5, 2025 – ArisGlobal, an AI-first technology company at the forefront of life sciences and creator of LifeSphere®, today announced that a prominent Japan-based pharmaceutical company has adopted  LifeSphere® Safety, ArisGlobal’s next-generation pharmacovigilance platform, marking a strategic shift toward smarter, AI-enabled safety operations. The implementation spans global operations in Japan, the United States, and Europe.

The company processes approximately twenty thousand safety cases each year, previously handled through a legacy system. By upgrading to LifeSphere’s modern multi-tenant cloud platform, the organization aims to strengthen compliance, reduce manual burden, and improve global coordination. The new deployment includes:

• LifeSphere® MultiVigilance – A unified platform for end-to-end case processing and safety data management, designed to scale globally while supporting local regulatory compliance.
• LifeSphere® Reporter – A multilingual field reporting solution that streamlines adverse event intake from field representatives and affiliates, supporting real-time, global capture of critical safety data.
• LifeSphere® Business Intelligence – A powerful analytics and reporting tool that delivers real-time insights into safety operations, enabling data-driven decision-making, compliance tracking, and operational optimization.

“By consolidating on a modern, cloud-based platform, this customer now has the flexibility, scalability, and automation-readiness to meet today’s regulatory demands and tomorrow’s innovation goals,” said Zhiyi Chen, Senior Vice President, APAC, ArisGlobal. “This rollout demonstrates how LifeSphere empowers our customers to move forward with confidence, even in highly complex, multi-region environments.”

This milestone adds to ArisGlobal’s growing footprint in Japan and the broader APAC region , contributing to 10 implementations across APAC in the first half of 2025 — a 233% YoY increase that underscores the company’s position as a trusted technology partner for life sciences organizations accelerating safety innovation through AI-powered transformation.